DMAC
DiaMedica Therapeutics Inc. · Healthcare
Director Randall Michael Giuffre bought $35K of DiaMedica Therapeutics Inc.
Bought$34,709
$1.40Price
24,874Shares
+11%Stake
What DMAC did for a copier
- $1,000 copied at Thu, Dec 8 close, $1.44
- $1,056
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Jan 24 close.
Randall Michael Giuffre's record
3 other buys with 3 months of prices since 2018: on average +9.2% against the S&P 500, and 2 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Dec 6. Filed Thu, Dec 8, 11:55 AM ET, during the session. Returns use the Dec 8 close and the Jan 24 close. Not investment advice.